✉news ScienceBiology first seen 13 h ago, last 1 h ago, peak #13
B7-33 Peptide Draws Attention in Biased Ligand Research
Original: B7-33 and the Expanding Frontier of Biased Ligand Research
B7-33, a relaxin-family peptide analogue studied for its biased signaling properties, is being highlighted as an example of how biased ligand research is expanding in pharmacology. Researchers interested in compounds that activate beneficial pathways while avoiding unwanted ones are citing B7-33 as a case study in designing drugs with fewer side effects. Discussion centers on its potential in fibrosis and cardiovascular research.
Why now: Growing scientific interest in biased agonists is putting specific peptide candidates like B7-33 in the spotlight.
B7-33biased ligand researchpharmacology
Rank over time, top of the chart is #1. 3 snapshots from 5 h ago to 1 h ago.
Evidence
- B7-33 and the Expanding Frontier of Biased Ligand Research · Tifton Gazette
API: https://socialmediatrends-api.osmike.com/v1/trends/635973